Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion

Chertow, 2006, Mortality after acute renal failure: models for prognostic stratification and risk adjustment, Kidney Int., 70, 1120, 10.1038/sj.ki.5001579 Woodrow, 1992, Cause of death in acute renal failure, Nephrol. Dial. Transplant., 7, 230, 10.1093/oxfordjournals.ndt.a092111 McCarthy, 1996, Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras, Mayo Clin. Proc., 71, 117, 10.4065/71.2.117 Levy, 1996, The effect of acute renal failure on mortality. A cohort analysis, JAMA, 275, 1489, 10.1001/jama.1996.03530430033035 Chertow, 1998, Independent association between acute renal failure and mortality following cardiac surgery, Am. J. Med., 104, 343, 10.1016/S0002-9343(98)00058-8 Polo-Romero, 2004, Effect of N-acetylcysteine on antioxidant status in glycerol-induced acute renal failure in rats, Ren. Fail., 26, 613, 10.1081/JDI-200037115 Rodrigo, 2004, Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wine, Nephrol. Dial. Transplant., 19, 2237, 10.1093/ndt/gfh369 Singh, 2004, Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney, Toxicology, 201, 143, 10.1016/j.tox.2004.04.018 Aydogdu, 2004, Effects of exogenous melatonin on myoglobinuric acute renal failure in the rats, Ren. Fail., 26, 479, 10.1081/JDI-200033020 Chander, 2005, Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure, Biochim. Biophys. Acta, 1723, 208, 10.1016/j.bbagen.2005.01.016 Aydogdu, 2006, Protective effects of l-carnitine on myoglobinuric acute renal failure in rats, Clin. Exp. Pharmacol. Physiol., 33, 119, 10.1111/j.1440-1681.2006.04336.x Koyner, 2008, Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?, Nephron. Exp. Nephrol., 109, e109, 10.1159/000142935 Cocheme, 2007, Mitochondrial targeting of quinones: therapeutic implications, Mitochondrion, 7, S94, 10.1016/j.mito.2007.02.007 Skulachev, 2007, A biochemical approach to the problem of aging: “megaproject” on membrane-penetrating ions. The first results and prospects, Biochemistry (Mosc), 72, 1385, 10.1134/S0006297907120139 Skulachev, 2009, An attempt to prevent senescence: a mitochondrial approach, Biochim. Biophys. Acta, 1787, 437, 10.1016/j.bbabio.2008.12.008 Liberman, 1969, Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria, Nature, 222, 1076, 10.1038/2221076a0 Antonenko, 2008, Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments, J. Membr. Biol., 222, 141, 10.1007/s00232-008-9108-6 Bakeeva, 2008, Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke), Biochemistry (Mosc), 73, 1288, 10.1134/S000629790812002X Agapova, 2008, Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells, Biochemistry (Mosc), 73, 1300, 10.1134/S0006297908120031 Neroev, 2008, Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals, Biochemistry (Mosc), 73, 1317, 10.1134/S0006297908120043 Anisimov, 2008, Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence, Biochemistry (Mosc), 73, 1329, 10.1134/S0006297908120055 Plotnikov, 2007, The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney, Kidney Int., 72, 1493, 10.1038/sj.ki.5002568 Plotnikov, 2009, Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria, Biochim. Biophys. Acta, 1792, 796, 10.1016/j.bbadis.2009.06.005 Feldkamp, 2009, Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia–reoxygenation, Am J Physiol Renal Physiol, 297, F1632, 10.1152/ajprenal.00422.2009 Skulachev, 2010, Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs), Biochim. Biophys. Acta, 1797, 878, 10.1016/j.bbabio.2010.03.015 Plotnikov, 2010, New-generation skulachev ions exhibiting nephroprotective and neuroprotective properties, Biochemistry (Mosc), 75, 145, 10.1134/S0006297910020045 Zurovsky, 1993, Models of glycerol-induced acute renal failure in rats, J. Basic Clin. Physiol. Pharmacol., 4, 213, 10.1515/JBCPP.1993.4.3.213 Mihara, 1978, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test, Anal. Biochem., 86, 271, 10.1016/0003-2697(78)90342-1 Zager, 2004, Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury, Kidney Int., 65, 2123, 10.1111/j.1523-1755.2004.00638.x Dobashi, 2002, Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia–reperfusion injury in rat kidney, Mol. Cell. Biochem., 240, 9, 10.1023/A:1020629020443 Serviddio, 2008, Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury, Nephrol. Dial. Transplant., 23, 1504, 10.1093/ndt/gfm779 Rouschop, 2008, Ischemia–reperfusion treatment: opportunities point to modulation of the inflammatory response, Kidney Int., 73, 1333, 10.1038/ki.2008.156 Chatterjee, 2007, Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review, Naunyn Schmiedebergs Arch. Pharmacol., 376, 1, 10.1007/s00210-007-0183-5 Plotnikov, 2008, Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin, FEBS Lett., 582, 3117, 10.1016/j.febslet.2008.08.002 Zorov, 2000, Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes, J. Exp. Med., 192, 1001, 10.1084/jem.192.7.1001 Zorov, 2006, Mitochondrial ROS-induced ROS release: an update and review, Biochim. Biophys. Acta, 1757, 509, 10.1016/j.bbabio.2006.04.029 Zager, 1996, Rhabdomyolysis and myohemoglobinuric acute renal failure, Kidney Int., 49, 314, 10.1038/ki.1996.48 Vanholder, 2000, Rhabdomyolysis, J. Am. Soc. Nephrol., 11, 1553, 10.1681/ASN.V1181553 Zager, 1996, Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria, Kidney Int., 49, 741, 10.1038/ki.1996.103 Reeder, 2002, Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage, Biochem. Soc. Trans., 30, 745, 10.1042/bst0300745 Anagnostou, 1990, Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells, Proc. Natl. Acad. Sci. U. S. A., 87, 5978, 10.1073/pnas.87.15.5978 Digicaylioglu, 1995, Localization of specific erythropoietin binding sites in defined areas of the mouse brain, Proc. Natl. Acad. Sci. U. S. A., 92, 3717, 10.1073/pnas.92.9.3717 Brines, 2005, Emerging biological roles for erythropoietin in the nervous system, Nat. Rev. Neurosci., 6, 484, 10.1038/nrn1687 Fliser, 2006, Mechanisms of disease: erythropoietin—an old hormone with a new mission?, Nat. Clin. Pract. Cardiovasc. Med., 3, 563, 10.1038/ncpcardio0609 Sharples, 2006, Erythropoietin in experimental acute renal failure, Nephron. Exp. Nephrol., 104, e83, 10.1159/000094546 Sutherland, 1993, Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling, Biochem. J., 296, 15, 10.1042/bj2960015 Juhaszova, 2004, Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore, J. Clin. Invest., 113, 1535, 10.1172/JCI19906 Skulachev, 1996, Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants, Q. Rev. Biophys., 29, 169, 10.1017/S0033583500005795 Ohori, 2008, Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis, Am. J. Physiol. Heart Circ. Physiol., 295, H2079, 10.1152/ajpheart.00092.2008 Burger, 2009, Molecular basis of cardioprotection by erythropoietin, Curr. Mol. Pharmacol., 2, 56, 10.2174/1874467210902010056 Toba, 2009, Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat, Eur. J. Pharmacol., 612, 106, 10.1016/j.ejphar.2009.03.065 Jelkmann, 1997, Effects of antioxidant vitamins on renal and hepatic erythropoietin production, Kidney Int., 51, 497, 10.1038/ki.1997.69 Neumcke, 1999, Effects of pro- and antioxidative compounds on renal production of erythropoietin, Endocrinology, 140, 641, 10.1210/endo.140.2.6529